Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
GLP-1 therapies influence pathways tied to addiction and reward, according to the Endocrine Society A randomized clinical trial published in JAMA Psychiatry found semaglutide reduced alcohol cravings and consumption Users commonly report: Reduced desire to drink Feeling full faster when drinking Less reward from alcohol The data: early, but directionally consistent While long-term industry sales data is still developing, the early signals from clinical studies, observational research, and population polling all point in the same direction: GLP-1 use is associated with lower alcohol consumption for at least some users
A probiotic with strain-level transit-time data may modestly support gut function as an adjunct
Ozempic: What Is It
A 2024 clinical trial in chronic rhinosinusitis failed, highlighting the risks associated with indication expansion
Frequently Asked Questions Everything you need to know about GLP-1 weight loss with ZYP Medical
US$ 22.30
US$ 25.31
US$ 24.33
US$ 23.11
US$ 28.61
